The process of drug development begins with selecting a disease, followed by identifying a target, and finally designing the molecule. Key factors include ensuring the target is novel, effective, and commercially viable to attract investor interest. A focus on patient needs remains paramount, but the financial realities of biotechnology demand that only the most promising targets receive funding for development.
